94% of patients with cancer respond well to COVID-19 vaccines...


EurekAlert | 2021-07-01 04:00 UTC

More than 9 of 10 patients with cancer showed good immune response to the COVID-19 mRNA vaccines after receiving both doses, but subsets of high-risk patients did not, according to a study conducted by researchers at the Mays Cancer Center, home to UT Hea

By Anonymous Submission on 2021-07-01 06:39 UTC
  • Need an account?  
    or